Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug-Reference-Cited by-同舟云学术

Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug

Published:2004-12-08 Issue:6 Volume:51 Page:933-940
ISSN:0004-3591
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Mazzuca Steven A.,Brandt Kenneth D.,Katz Barry P.,Lane Kathleen A.,Bradley John D.,Heck Louis W.,Hugenberg Steven T.,Manzi Susan,Moreland Larry W.,Oddis Chester V.,Schnitzer Thomas J.,Sharma Leena,Wolfe Frederick,Yocum David E.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference27 articles.

1. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study;Guccione;Am J Public Health,1994

2. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Center for Devices and Radiological Health 2003 http://www.fda.gov/cder/guidance/2199dft.doc

3. Is conventional radiography suitable for evaluation of a disease-modifying drug in patients with knee osteoarthritis?;Mazzuca;Osteoarthritis Cartilage,1997

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recognising the importance of the research nurse and study coordinators in enhancing retention of people with haemophilia in clinical trials;The Journal of Haemophilia Practice;2023-01-01

2. One-Year, Efficacy and Safety Open Label Study, with a Single Injection of a New Hyaluronan for Knee OA: The SOYA Trial;Journal of Pain Research;2021-07

3. Biomarkers of inflammation – LBP and TLR— predict progression of knee osteoarthritis in the DOXY clinical trial;Osteoarthritis and Cartilage;2018-12

4. Discontinuing a non-steroidal anti-inflammatory drug (NSAID) in patients with knee osteoarthritis: Design and protocol of a placebo-controlled, noninferiority, randomized withdrawal trial;Contemporary Clinical Trials;2018-02

5. Improvement in condition-specific and generic quality of life outcomes in patients with knee osteoarthritis following single-injection Synvisc: results from the LOBRAS study;Current Medical Research and Opinion;2016-12-16